Moberg Pharma: Bayer exits Europe pact with Moberg for nail fungus drug after Phase 3 fail

Moberg Pharma's Terclara has flunked a late-stage test evaluating less frequent maintenance dosing for fungal nail infection, prompting Bayer to pull out of planned launch activities in Europe and ending their partnership. The Swedish drugmaker ...